Point-of-Care Products: Highlights, Trends and Emerging Technologies
Point-of-care testing aims to improve health care with quick turnaround times.
Read MorePosted by Clinical Lab Products | Sep 1, 2009 | Cancer, Miscellaneous |
Point-of-care testing aims to improve health care with quick turnaround times.
Read MorePosted by Clinical Lab Products | Jul 15, 2009 | Cancer, Miscellaneous |
Fenwal Inc announced that it has signed a five-year exclusive worldwide agreement with Verax Biomedical Incorporated to market, sell and distribute Verax’s unique PanGenera Detection (PGD) technology, a rapid diagnostic test used to detect bacterial contaminants in donated blood platelets.
Read MorePosted by Clinical Lab Products | Apr 2, 2008 | Miscellaneous |
CLP surveys the evolving landscape of point-of-care products.
Read MorePosted by Clinical Lab Products | Apr 16, 2007 | Miscellaneous |
StatStrip Blood glucose monitor corrects hematocrit interference A blood glucose monitoring system from Nova Biomedical, Waltham, Mass, elevates bedside glucose testing to a new level of analytical performance comparable to the quality of cen
Read MorePosted by Clinical Lab Products | Nov 2, 2005 | Miscellaneous |
By Dana Hinesly Since its introduction in the 1970s, point-of-care (POC) glucose testing has gained steady acceptance in the medical community. The ability to monitor a patients blood-sugar level within minutes revolutionized the care physi
Read More